How Frequent Is Bleeding With NOACs Bleeding Risk HASBLED Bleeding Scores in AF Biomarkers in AF Reasons for and Implications of Elevated GDF15 Level GDF15 in ARISTOTLE GDF15 Strongest Bleeding Marker ID: 716053
Download Presentation The PPT/PDF document "The ABCs of AF Goals Bleeding With Warfa..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
The ABCs of AFSlide2Slide3
GoalsSlide4
Bleeding With WarfarinSlide5
How Frequent Is Bleeding With NOACs?Slide6
Bleeding Risk: HAS-BLEDSlide7
Bleeding Scores in AFSlide8
Biomarkers in AFSlide9
Reasons for and Implications of Elevated GDF-15 LevelSlide10
GDF-15 in ARISTOTLESlide11
GDF-15
Strongest Bleeding MarkerSlide12
Risk Scores Related to
Cardiac Biomarker LevelsSlide13
The Novel ABC (Age, Biomarkers, Clinical History)- Bleeding Risk Score in AFSlide14
3 Dimensions of AF TreatmentSlide15
Validation and Calibration
ABC-Bleeding Risk Score Slide16
Discrimination With ABC-Bleeding in Comparison With Other Bleeding Risk Scores in AFSlide17
Risk Stratification With ABC-Bleeding Within Other Bleeding ScoresSlide18
ABC Risk Scores in AFSlide19
ABC-AF Pragmatic Clinical Study DesignSlide20
Expected Trial Outcomes: ABC-AFSlide21
Future ConsiderationsSlide22
Risk Stratification and Biomarkers: SummarySlide23
Key TakeawaysSlide24
AbbreviationsSlide25
Abbreviations (cont)